<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="combined drugs and their target viruses. Mathematical models of viral" exact="infection" post="dynamics provide an ideal tool for this purpose. Additionally,"/>
 <result pre="elucidated the key steps of viral replication cycles and viral" exact="infection" post="dynamics, such as the half-life of viruses and how"/>
 <result pre="yet to be properly explored. Multi-drug administration is a standard" exact="treatment" post="for HIV and HCV infection, and is also required"/>
 <result pre="antiviral therapyHepatology200746162110.1002/hep.2165717596864 18.DahariHSainzBPerelsonASUprichardSLModeling subgenomic hepatitis C virus RNA kinetics during" exact="treatment" post="with alpha interferonJ Virol2009836383639010.1128/JVI.02612-0819369346 19.LewinSRRibeiroRMWaltersTLauGKBowdenSLocarniniSPerelsonASAnalysis of hepatitis B viral"/>
 <result pre="profiles of hepatitis B virus during antiviral therapyHepatology200949323810.1002/hep.2258619065674 21.BeaucheminCAAMcSharryJJDrusanoGLNguyenJTWentGTRibeiroRMPerelsonASModeling amantadine" exact="treatment" post="of influenza A virus in vitroJ Theor Biol200825443945110.1016/j.jtbi.2008.05.03118653201 22.DobrovolnyHMGieschkeRDaviesBEJumbeNLBeaucheminCAANeuraminidase"/>
 <result pre="influenza A virus in vitroJ Theor Biol200825443945110.1016/j.jtbi.2008.05.03118653201 22.DobrovolnyHMGieschkeRDaviesBEJumbeNLBeaucheminCAANeuraminidase inhibitors for" exact="treatment" post="of human and avian strain influenza: A comparative modeling"/>
 <result pre="review from a response surface perspectivePharmacol Rev1995473313857568331 30.TallaridaRJDrug synergism: its" exact="detection" post="and applicationsJ Pharmacol Exp Ther200129886587211504778 31.LoeweSThe problem of synergism"/>
 <result pre="decline during telaprevir-based therapy increases with drug effectiveness: implications for" exact="treatment" post="durationHepatology2011531801180810.1002/hep.2427221384401 51.GuedjJNeumannAUUnderstanding hepatitis C viral dynamics with direct-acting antiviral"/>
 <result pre="agents due to the interplay between intracellular replication and cellular" exact="infection" post="dynamicsJ Theor Biol201026733034010.1016/j.jtbi.2010.08.03620831874 52.GuedjJDahariHRongLSansoneNDNettlesRECotlerSJLaydenTJUprichardSLPerelsonASModeling shows that the NS5A inhibitor"/>
 <result pre="U S A20131103991399610.1073/pnas.120311011023431163 53.RongLGuedjJDahariHCoffieldDJLeviMSmithPPerelsonASAnalysis of hepatitis C virus decline during" exact="treatment" post="with the protease inhibitor danoprevir using a multiscale modelPLoS"/>
</results>
